Brian Kornblit

Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial

Brenda M. Sandmaier, Brian Kornblit, Barry E. Storer et al. · The Lancet Haematology · 2019 · 110 citations · Full text

Transplantation, Marrow Transplantation, Stem Cell Transplantation +6

Reagents for Astatination of Biomolecules. 6. An Intact Antibody Conjugated with a Maleimido-<i>closo</i>-Decaborate(2-) Reagent via Sulfhydryl Groups Had Considerably Higher Kidney Concentrations than the Same Antibody Conjugated with an Isothiocyanato-<i>closo</i>-Decaborate(2-) Reagent via Lysine Amines

D. Scott Wilbur, Ming‐Kuan Chyan, Hirohisa Nakamae et al. · Bioconjugate Chemistry · 2012 · 68 citations · Full text

Cell Therapy, Lysine Amines, Glycobiology +24

Improved Overall Survival, Relapse-Free-Survival, and Less Graft-vs.-Host-Disease in Patients With High Immune Reconstitution of TCR Gamma Delta Cells 2 Months After Allogeneic Stem Cell Transplantation

Lia Minculescu, Hanne Vibeke Marquart, Lars P. Ryder et al. · Frontiers in Immunology · 2019 · 65 citations · Full text

Durable donor engraftment after radioimmunotherapy using α-emitter astatine-211–labeled anti-CD45 antibody for conditioning in allogeneic hematopoietic cell transplantation

Yun Chen, Brian Kornblit, Donald K. Hamlin et al. · Blood · 2011 · 61 citations · Full text

Association of HMGB1 polymorphisms with outcome in patients with systemic inflammatory response syndrome

Brian Kornblit, Lea Munthe‐Fog, Hans O. Madsen et al. · Critical Care · 2008 · 61 citations · Full text